ES2211373T1 - Nuevas formas cristalinas de oxcarbazepina y procedimientos para su preparacion. - Google Patents

Nuevas formas cristalinas de oxcarbazepina y procedimientos para su preparacion.

Info

Publication number
ES2211373T1
ES2211373T1 ES02718948T ES02718948T ES2211373T1 ES 2211373 T1 ES2211373 T1 ES 2211373T1 ES 02718948 T ES02718948 T ES 02718948T ES 02718948 T ES02718948 T ES 02718948T ES 2211373 T1 ES2211373 T1 ES 2211373T1
Authority
ES
Spain
Prior art keywords
oxcarbazepine
solution
approximately
procedure
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES02718948T
Other languages
English (en)
Spanish (es)
Inventor
Judith Aronhime
Ben-Zion Dolitzky
Yana Berkovich
Nissim Garth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of ES2211373T1 publication Critical patent/ES2211373T1/es
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
ES02718948T 2001-02-12 2002-02-12 Nuevas formas cristalinas de oxcarbazepina y procedimientos para su preparacion. Pending ES2211373T1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26831401P 2001-02-12 2001-02-12
US268314P 2001-02-12

Publications (1)

Publication Number Publication Date
ES2211373T1 true ES2211373T1 (es) 2004-07-16

Family

ID=23022405

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02718948T Pending ES2211373T1 (es) 2001-02-12 2002-02-12 Nuevas formas cristalinas de oxcarbazepina y procedimientos para su preparacion.

Country Status (11)

Country Link
US (1) US7183272B2 (cg-RX-API-DMAC7.html)
EP (1) EP1368322A4 (cg-RX-API-DMAC7.html)
JP (1) JP2004526706A (cg-RX-API-DMAC7.html)
AU (1) AU2002250057A1 (cg-RX-API-DMAC7.html)
CA (1) CA2437402A1 (cg-RX-API-DMAC7.html)
DE (1) DE02718948T1 (cg-RX-API-DMAC7.html)
ES (1) ES2211373T1 (cg-RX-API-DMAC7.html)
HU (1) HUP0303154A3 (cg-RX-API-DMAC7.html)
IL (1) IL157351A0 (cg-RX-API-DMAC7.html)
TR (1) TR200400313T3 (cg-RX-API-DMAC7.html)
WO (1) WO2002064557A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2486560A1 (en) 2002-06-14 2003-12-24 Taro Pharmaceuticals U.S.A., Inc. Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide
GB0223224D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds
US20060166968A1 (en) * 2004-07-16 2006-07-27 Sundaram Venkataraman Crystalline form of oxcarbazepine
EP1828098A1 (en) * 2005-11-22 2007-09-05 Teva Pharmaceutical Industries Ltd Crystal forms of cinacalcet hci and processes for their preparation
TWI363058B (en) * 2006-04-05 2012-05-01 Opko Health Inc Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
ES2396051T3 (es) 2006-04-26 2013-02-18 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal
ITMI20062449A1 (it) * 2006-12-19 2008-06-20 Dipharma Spa Forma cristallina di rabeprazolo sodico
ITMI20071502A1 (it) * 2007-07-25 2009-01-26 Archimica Srl Procedimento per la preparazione di formulazioni solide a rilascio controllato contenenti oxcarbazepina e formulazioni ottenibili con tale procedimento
EP2464230B1 (en) * 2009-08-14 2016-10-05 OPKO Health, Inc. Intravenous formulations of rolapitant
WO2011071853A2 (en) 2009-12-07 2011-06-16 Academic Pharmaceuticals Incorporated Parenteral formulation of clopidogrel
TWI665190B (zh) 2013-11-15 2019-07-11 阿克比治療有限公司 {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式,其組合物及用途
AU2019348194B2 (en) 2018-09-28 2025-04-03 Griffith University Agents and methods for modulating pathogen activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) * 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
FI75561C (fi) 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
FR2700117B1 (fr) 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
IT1272897B (it) 1995-01-13 1997-07-01 I F C Iniziative Finanziaarie Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
US6670472B2 (en) 2001-10-09 2003-12-30 Max India Limited Process for the preparation of 10-methoxycarbamazepine
CA2486560A1 (en) 2002-06-14 2003-12-24 Taro Pharmaceuticals U.S.A., Inc. Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide

Also Published As

Publication number Publication date
DE02718948T1 (de) 2004-07-08
WO2002064557A9 (en) 2002-11-28
US7183272B2 (en) 2007-02-27
WO2002064557A2 (en) 2002-08-22
IL157351A0 (en) 2004-02-19
HUP0303154A3 (en) 2009-08-28
JP2004526706A (ja) 2004-09-02
CA2437402A1 (en) 2002-08-22
EP1368322A4 (en) 2004-03-17
TR200400313T3 (tr) 2004-04-21
AU2002250057A1 (en) 2002-08-28
EP1368322A2 (en) 2003-12-10
WO2002064557A3 (en) 2002-10-24
HUP0303154A2 (hu) 2004-01-28
US20030004154A1 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
ES2877404T3 (es) Derivados de indol mono o disustituidos como inhibidores de la replicación viral del dengue
ES2961843T3 (es) Gamma-carbolinas condensadas con heterociclo deuteradas como antagonistas de los receptores de 5-HT2A
KR101496508B1 (ko) 독성을 감소시키고 질환을 치료하거나 예방하기 위한 화합물, 조성물과 방법
ES2893298T3 (es) Derivados de indol mono- o disustituidos como inhibidores de la replicación viral del dengue
US20220211678A1 (en) Uses of (+)-a-dihydrotetrabenazine in methods of treating movement disorder
RO118372B1 (ro) Antagonisti nepeptidici ai receptorului de tahikinina, procedeu de preparare a acestora si compozitie farmaceutica
AR033525A1 (es) Arilmetilaminas sustituidas, composiciones farmaceuticas, uso de las mismas para la manufactura de un medicamento
CA2944755A1 (en) Organic compounds
AR044775A1 (es) Composiciones farmaceuticas de atorvastatina
AU2005216978A1 (en) Isoquinoline derivatives and methods of use thereof
CN101528269A (zh) 阿片样物质止痛剂的制备和应用
JP2014513101A (ja) 新規のビスアミノキノリン化合物、それから調製した医薬組成物、及びそれらの使用
UY27592A1 (es) Nuevo uso
RU2000103033A (ru) Термодинамически стабильная модификация 1-(4-карбазолилокси)-3-[2-(2-метоксифенокси)этиламино]-2-пропанола, способ ее получения и содержащие ее фармацевтические композиции
AR050615A1 (es) Composiciones farmaceuticas para la administracion oral
JPH0144170B2 (cg-RX-API-DMAC7.html)
RU2022104034A (ru) Фармацевтические композиции
AR030039A1 (es) Composicion farmaceutica que comprende una droga inhibidora selectiva de la ciclooxigenasa-2, su uso en la fabricacion de un medicamento para tratar o prevenir afecciones mediadas por la ciclooxigenasa-2 y metodo para hacer dicho medicamento
JP3130040B2 (ja) アリールモルホリン化合物、製造方法および使用
AR089122A1 (es) Formulaciones orales para tratar la sobrecarga de metales
JP2004526706A5 (cg-RX-API-DMAC7.html)
EP2325187A1 (en) The hydrosulfate of prasugrel, its pharmaceutical combination and uses thereof
US11007169B2 (en) Cis-gnetin H and trans-gnetin H as therapeutic agents
CA2022236A1 (en) Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders
ES2634666T3 (es) Polimorfo de 3-(dihidroisoindolinon-2-il sustituido)-2,6-dioxopiperidina, y composiciones farmacéuticas de la misma